Literature DB >> 26405413

Retroperitoneal Sarcoma. Outcome Analysis in a Teaching Hospital in Eastern India- a Perspective.

Nilanjan Panda1, Ruchira Das2, Souvik Banerjee3, Sajib Chatterjee4, Manas Gumta4, Samik Kumar Bandyopadhyay1.   

Abstract

Primary Retroperitoneal Sarcomas are relatively uncommon tumors with varied manifestations, ill-defined prognostic factors and uncertain management modalities. We undertook this study to review patients who presented with primary or recurrent RPS at our institute during the study period. Between 2008 and 2010, 23 patients were evaluated. Statistical analysis was done using the chi square test or Fisher's exact test. Recurrence was calculated using Kaplan Meier curves. The log-rank test was used to compare differences in survival or relapse. Among the 23 patients, 13 were males. Majority (52.2 %) presented with abdominal lump located in umbilical and right hypochondrial region. Surgery was done in 20 (87 %) patients for primary RPS and three (13 %) for recurrent RPS at initial presentation. 14 (61 %) received complete tumor resection, six (27 %) incomplete microscopic resection, and three (13 %) incomplete macroscopic resection. In univariate Cox's proportional hazard model on time ('timer') to event ('relapse') analysis, all the variables like older age (p = 0.027), male sex (p = 0.012), incomplete resection (p = 0.008), large size (0.047) and high grade (p = 0.047) became significant predictor of early recurrence. However, multivariate analysis showed that only extent of resection, grade and sex were statistically significant predictors. Complete tumor resection of retroperitoneal sarcoma (n = 14) was associated with a significantly lesser recurrence compared with unclear resection (n = 9, p = 0.002). The median time between surgery and first recurrence was 15 months. High-grade sarcomas had a significantly higher recurrence (n = 10; median: 24, 95 % CI) than low-grade sarcomas (n = 13, median: 15; 95 %CI P < 0.01). Furthermore, the survival of male patients were worse than that of females (p = 0.036). Completeness of resection, tumor grade and sex are prognostic factors of retroperitoneal soft tissue sarcomas.

Entities:  

Keywords:  Chemotherapy; Radiotherapy; Retroperitoneal sarcoama; Surgery

Year:  2015        PMID: 26405413      PMCID: PMC4577479          DOI: 10.1007/s13193-015-0404-1

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  26 in total

1.  Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient.

Authors:  Zheng Zhou; Theodore P McDade; Jessica P Simons; Sing Chau Ng; Laura A Lambert; Giles F Whalen; Shimul A Shah; Jennifer F Tseng
Journal:  Arch Surg       Date:  2010-05

2.  Primary retroperitoneal sarcomas: common symptoms, common diagnoses, uncommon disease.

Authors:  B H Ziran; J T Makley; J R Carter
Journal:  Clin Orthop Relat Res       Date:  1996-10       Impact factor: 4.176

3.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.

Authors: 
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

4.  Effect of resection and outcome in patients with retroperitoneal sarcoma.

Authors:  Antonio Chiappa; Andrew P Zbar; Roberto Biffi; Emilio Bertani; Francesca Biella; Giuseppe Viale; Ugo Pace; Giancarlo Pruneri; Roberto Orecchia; Roberta Lazzari; Davide Poldi; Bruno Andreoni
Journal:  ANZ J Surg       Date:  2006-06       Impact factor: 1.872

5.  Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?

Authors:  D Shibata; J J Lewis; D H Leung; M F Brennan
Journal:  J Am Coll Surg       Date:  2001-10       Impact factor: 6.113

Review 6.  Retroperitoneal and visceral sarcomas: issues for the general surgeon.

Authors:  Charles E Woodall; Charles R Scoggins
Journal:  Am Surg       Date:  2007-06       Impact factor: 0.688

Review 7.  Sarcoma.

Authors:  Keith M Skubitz; David R D'Adamo
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

Review 8.  Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.

Authors:  J J Lewis; D Leung; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

9.  Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience.

Authors:  Imran Hassan; Saung Z Park; John H Donohue; David M Nagorney; Paul A Kay; Antonio G Nasciemento; Cathy D Schleck; Duane M Ilstrup
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

10.  Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.

Authors:  Chun-Qiu Chen; Lu Yin; Cheng-Hong Peng; Yong Cai; Ya-Fen Li; Ren Zhao; Hui-Jiang Zhou; Hong-Wei Li
Journal:  Chin Med J (Engl)       Date:  2007-06-20       Impact factor: 2.628

View more
  5 in total

1.  Retroperitoneal Sarcomas: Prognostic Factors and Outcomes of a Series of Patients Treated at a Single Institution.

Authors:  Shraddha Patkar; Abhay K Kattepur; Rajesh Shinde; Mahesh Goel
Journal:  Indian J Surg Oncol       Date:  2020-01-15

Review 2.  Retroperitoneal Sarcomas: a Current Review on Management.

Authors:  Shraddha Patkar; Abhay K Kattepur; Nehal Khanna; Jyoti Bajpai
Journal:  Indian J Surg Oncol       Date:  2022-02-21

3.  Permanent Iodine-125 Seed Implantation for the Treatment of Nonresectable Retroperitoneal Malignant Tumors.

Authors:  Qingchun Li; Yuan Tian; Dongyan Yang; Yun Liang; Xianbin Cheng; Baodong Gai
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

4.  Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India.

Authors:  Manjit K Rana; Tushar S Barwal; Uttam Sharma; Richika Bansal; Karuna Singh; Amrit Pal S Rana; Aklank Jain; Utkarshni Khera
Journal:  Cureus       Date:  2021-06-21

Review 5.  Indian data on bone and soft tissue sarcomas: A summary of published study results.

Authors:  Anant Ramaswamy; Bharat Rekhi; Sameer Bakhshi; Sachin Hingmire; Manish Agarwal
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.